Sionna Therapeutics, Inc. (SION)
3.28
-0.45
(-12.06%)
USD |
NASDAQ |
Nov 05, 16:00
3.31
+0.03
(+0.91%)
After-Hours: 20:00
Sionna Therapeutics SG&A Expense (TTM) : 37.45M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.45M |
| March 31, 2026 | 33.36M |
| December 31, 2025 | 28.72M |
| September 30, 2025 | 24.16M |
| June 30, 2025 | 16.39M |
| March 31, 2025 | 9.871M |
| Date | Value |
|---|---|
| December 31, 2024 | 3.88M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.563B |
| Capricor Therapeutics, Inc. | 35.43M |
| ARS Pharmaceuticals, Inc. | 284.49M |
| ACADIA Pharmaceuticals, Inc. | 486.89M |
| Immunic, Inc. | 27.24M |